Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inspire Medical Systems, Inc. Common Stock (NY:INSP)

142.00 -7.69 (-5.13%)
Streaming Delayed Price Updated: 1:17 PM EDT, Apr 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inspire Medical Systems, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Inspire Medical Systems's Return On Capital Employed Insights
Inspire Medical Systems (NYSE:INSP) brought in sales totaling $109.19 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 16.27%, resulting in a loss of $16.85... 
Via Benzinga
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Earnings Preview For Inspire Medical Systems
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Inspire Medical Systems: Q2 Earnings Insights
Inspire Medical Systems (NYSE:INSP) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Inspire Medical Systems Earnings Preview
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Inspire Medical Systems: Q1 Earnings Insights
Inspire Medical Systems (NYSE:INSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Inspire Medical Systems's Earnings Outlook
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade
Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
Upgrades 
Via Benzinga
Executive Chairman Bill Ford Continues To Buy More Ford Shares
I was recently listening to Barry’s Ritholtz’s Masters in Business podcast interview with Darren Palmer, the VP of Ford’s Global EV Program, and he... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
Executives Sell Over $640M Of 5 Stocks
Although oil futures traded higher on Wednesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects... 
Via Benzinga
Inspire Medical Clocks 70% Increase In Q4 Sales, Issues FY22 Guidance Ahead Of Consensus
Inspire Medical Systems Inc (NYSE: INSP) generated revenue of  
Via Benzinga
Inspire Medical Systems: Q4 Earnings Insights
Inspire Medical Systems (NYSE:INSP) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,... 
Via Benzinga
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. 
Via Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
Inspire Medical Expects Strong Q4 FY21 Revenue Growth
Inspire Medical Systems Inc (NYSE: INSP) expects Q4 FY21 revenue of $78.0 million - $78.4 million, up approximately 70% Y/Y and surpassing the consensus estimate of $65... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mixed After Dow Records Another High
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones surged to a new record closing high on Tuesday. Investors are awaiting earnings... 
Via Benzinga
5 Stocks To Watch For January 5, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.83 per share on revenue of... 
Via Benzinga
Atrial Fibrillation Market Is Expected To Reach  $11.123 Billion At A CAGR 11.2 % Through 2023
Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of... 
Via FinancialNewsMedia
Topics Death
Exposures Death
Inspire Medical Systems, inc (INSP) Q3 2021 Earnings Call Transcript
INSP earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... 
Via Benzinga
Exposures COVID-19
Analyst Ratings For Inspire Medical Systems
Analysts have provided the following ratings for Inspire Medical Systems (NYSE:IN... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Telsey Advisory Group reduced the price target for NIKE, Inc. (NYSE: NKE) from $180 to $176. NIKE shares fell 4.6% to $152.26 in pre-market trading. Wedbush raised the price... 
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
Looking into Inspire Medical Systems's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q2, Inspire Medical Systems (NYSE:INSP) posted sales of $52.96 million. Earnings were up 20.05%, but Inspire Medical... 
Via Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.